Choong-wae Pharm launches new diabetic agent Glufast tab.

Choonwae-Pharm said it has recently launched a new product Glufast tablet (mitiglinide) for the treatment of type II diabetes.

Glufast is an insulin secretagogue with a rapid onset and short duration of action, lowers post-meal glucose levels by improving the body's own ability to produce insulin.

"We believe that Glufast represents an important advance for physicians and their patients w...